Gene · 634
Papers3,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Counterintuitive Neutrophil-Mediated Pattern in COVID-19 Patients Revealed through Transcriptomics Analysis. | Viruses | 2022 | 36680144 | PubTator, text mining | PubMed |
| The Elusive Coreceptors for the SARS-CoV-2 Spike Protein. | Viruses | 2022 | 36680105 | PubTator, text mining | PubMed |
| Immune checkpoint blockade for locally advanced or recurrent/metastatic cervical cancer: An update on clinical data. | Front Oncol | 2022 | 36644634 | PubTator, text mining | PubMed |
| Neutrophil dynamics and inflammaging in acute ischemic stroke: A transcriptomic review. | Front Aging Neurosci | 2022 | 36620775 | PubTator, text mining | PubMed |
| Biomaterials Based on Chitosan and Its Derivatives and Their Potential in Tissue Engineering and Other Biomedical Applications-A Review. | Molecules | 2022 | 36615441 | PubTator, text mining | PubMed |
| Emerging Role of Neutrophil Extracellular Traps in Gastrointestinal Tumors: A Narrative Review. | Int J Mol Sci | 2022 | 36613779 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs as Epigenetic Regulators of Immune Checkpoints in Cancer Immunity. | Cancers (Basel) | 2022 | 36612180 | PubTator, text mining | PubMed |
| Mechanisms and Strategies to Overcome PD-1/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer. | Cancers (Basel) | 2022 | 36612100 | PubTator, text mining | PubMed |
| The role of extracellular vesicles and interleukin-8 in regulating and mediating neutrophil-dependent cancer drug resistance. | Front Oncol | 2022 | 36591453 | PubTator, text mining | PubMed |
| Increased CEACAM1 expression on peripheral blood neutrophils in patients with rheumatoid arthritis. | Front Immunol | 2022 | 36591283 | PubTator, text mining | PubMed |
| Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy. | Acta Pharm Sin B | 2022 | 36561994 | PubTator, text mining | PubMed |
| A Thermosensitive, Chitosan-Based Hydrogel as Delivery System for Antibacterial Liposomes to Surgical Site Infections. | Pharmaceutics | 2022 | 36559332 | PubTator, text mining | PubMed |
| Heart Uptake of [18F]Fluoro-4-Thia-Oleate in a Non-Alcoholic Fatty Liver Disease Mouse Model. | Pharmaceuticals (Basel) | 2022 | 36559027 | PubTator, text mining | PubMed |
| Hepatic Polarized Differentiation Promoted the Maturity and Liver Function of Human Embryonic Stem Cell-Derived Hepatocytes via Activating Hippo and AMPK Signaling Pathways. | Cells | 2022 | 36552880 | PubTator, text mining | PubMed |
| Transcriptome Analysis Reveals Vimentin-Induced Disruption of Cell-Cell Associations Augments Breast Cancer Cell Migration. | Cells | 2022 | 36552797 | PubTator, text mining | PubMed |
| Ellagic Acid Triggers the Necrosis of Differentiated Human Enterocytes Exposed to 3-Nitro-Tyrosine: An MS-Based Proteomic Study. | Antioxidants (Basel) | 2022 | 36552693 | PubTator, text mining | PubMed |
| Lung Cancer Immunotherapy: Beyond Common Immune Checkpoints Inhibitors. | Cancers (Basel) | 2022 | 36551630 | PubTator, text mining | PubMed |
| A Novel Therapeutic Target for Small-Cell Lung Cancer: Tumor-Associated Repair-like Schwann Cells. | Cancers (Basel) | 2022 | 36551618 | PubTator, text mining | PubMed |
| Mechanisms of Resistance in Gastroenteropancreatic Neuroendocrine Tumors. | Cancers (Basel) | 2022 | 36551599 | PubTator, text mining | PubMed |
| Delivery of Melittin as a Lytic Agent via Graphene Nanoparticles as Carriers to Breast Cancer Cells. | J Funct Biomater | 2022 | 36547538 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/634/papers?page=28